Literature DB >> 3884030

Tumour ploidy, response and survival in patients receiving endocrine therapy for advanced breast cancer.

R Stuart-Harris, D W Hedley, I W Taylor, A L Levene, I E Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3884030      PMCID： PMC1977139          DOI： 10.1038/bjc.1985.80

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  16 in total

1.  Combination treatment with tamoxifen and aminoglutethimide in advanced breast cancer.

Authors:  I E Smith; A L Harris; R Stuart-Harris; H T Ford; J C Gazet; H White; C L Harmer; L Carr; J A McKinna; M Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1983-05-21

Review 2.  Flow cytometry in clinical cancer research.

Authors:  B Barlogie; M N Raber; J Schumann; T S Johnson; B Drewinko; D E Swartzendruber; W Göhde; M Andreeff; E J Freireich
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

3.  Modal deoxyribonucleic acid value and survival in carcinoma of the breast.

Authors:  N B Atkin
Journal:  Br Med J       Date:  1972-01-29

4.  Tamoxifen versus aminoglutethimide versus combined tamoxifen and aminoglutethimide in the treatment of advanced breast carcinoma.

Authors:  I E Smith; A L Harris; M Morgan; J C Gazet; J A McKinna
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

5.  Ploidy, proliferative activity and estrogen receptor content in human breast cancer.

Authors:  M N Raber; B Barlogie; J Latreille; C Bedrossian; H Fritsche; G Blumenschein
Journal:  Cytometry       Date:  1982-07

6.  Flow cytometry of breast carcinoma: I. Relation of DNA ploidy level to histology and estrogen receptor.

Authors:  W Olszewski; Z Darzynkiewicz; P P Rosen; M K Schwartz; M R Melamed
Journal:  Cancer       Date:  1981-08-15       Impact factor: 6.860

7.  Aminoglutethimide in the treatment of advanced postmenopausal breast cancer.

Authors:  A L Harris; T J Powles; I E Smith
Journal:  Cancer Res       Date:  1982-08       Impact factor: 12.701

8.  Estrogen receptor content and ploidy of human mammary carcinoma.

Authors:  P Bichel; H S Poulsen; J Andersen
Journal:  Cancer       Date:  1982-11-01       Impact factor: 6.860

9.  Influence of cellular DNA content on disease-free survival of Stage II breast cancer patients.

Authors:  D W Hedley; C A Rugg; A B Ng; I W Taylor
Journal:  Cancer Res       Date:  1984-11       Impact factor: 12.701

10.  Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.

Authors:  T E Kute; H B Muss; D Anderson; K Crumb; B Miller; D Burns; L A Dube
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701
View more
  11 in total

Review 1.  Aneuploidy as a prognostic factor in breast cancer.

Authors:  A von Rosen
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

2.  DNA ploidy level and S-phase fraction as prognostic factors in breast cancer.

Authors:  T Yokoe; M Izuo; T Ishida; Y Iino; T Kawai
Journal:  Jpn J Surg       Date:  1990-09

3.  Influence of S-phase fraction on metastatic pattern and post-recurrence survival in a randomized mammography screening trial.

Authors:  T Hatschek; J Carstensen; G Fagerberg; O Stål; O Gröntoft; B Nordenskjöld
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

4.  Prognostic value of nuclear DNA content in breast cancer in relation to tumor size, nodal status, and estrogen receptor content.

Authors:  A von Rosen; L E Rutqvist; J Carstensen; A Fallenius; L Skoog; G Auer
Journal:  Breast Cancer Res Treat       Date:  1989-01       Impact factor: 4.872

5.  Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.

Authors:  J Harvey; N de Klerk; I Berryman; G Sterrett; M Byrne; J Papadimitriou
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

6.  Paragangliomas: neuroendocrine features and cytometric DNA distribution patterns. A clinico-pathological study of 22 cases.

Authors:  R Jovanovic; G W Hacker; U G Falkmer; S Falkmer; L Mendel; A H Graf; A Höög; V Kanjuh; C Silfverswärd; L Grimelius
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

7.  DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.

Authors:  A D Baildam; J Zaloudik; A Howell; D M Barnes; L Turnbull; R Swindell; M Moore; R A Sellwood
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

8.  Is DNA aneuploidy a good prognostic indicator in patients with advanced colorectal cancer?

Authors:  P J Finan; P Quirke; M F Dixon; J E Dyson; G R Giles; C C Bird
Journal:  Br J Cancer       Date:  1986-08       Impact factor: 7.640

9.  Tumour DNA ploidy as an independent prognostic factor in breast cancer.

Authors:  O P Kallioniemi; G Blanco; M Alavaikko; T Hietanen; J Mattila; K Lauslahti; T Koivula
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

10.  Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.

Authors:  A A Owainati; R A Robins; C Hinton; I O Ellis; C S Dowle; B Ferry; C W Elston; R W Blamey; R W Baldwin
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.